Major histocompatibility complex class I binding glycopeptides for the estimation of 'empty' class I molecules - PubMed (original) (raw)
Major histocompatibility complex class I binding glycopeptides for the estimation of 'empty' class I molecules
U M Abdel-Motal et al. J Immunol Methods. 1995.
Abstract
Different forms of major histocompatibility complex (MHC) class I heavy chains are known to be expressed on the cell surface, including molecules which are functionally 'empty'. Direct peptide binding to cells is obvious during sensitization of target cells in vitro for cytotoxic T lymphocyte killing and 'empty' MHC-I molecules are comparatively abundant on TAP-1/2 peptide transporter mutant cells. In the present work we have estimated the fraction of 'empty' MHC class I molecules using glycosylated peptides and cellular staining with carbohydrate specific monoclonal antibodies. Synthetic Db and Kb binding peptides were coupled at different positions with different di- or trisaccharides, using different spacing between the carbohydrate and the peptide backbone. Binding of sugar specific mAbs was compared in ELISA and cellular assays. An optimal Db binding glycopeptide was used for comparative staining with anti-Db and anti-carbohydrate monoclonal antibodies to estimate fractions of 'empty' molecules on different T lymphoid cells. On activated normal T cells, a large fraction of Db molecules were found to be 'empty'. The functional role of such 'empty' MHC class I molecules on T cells is presently unclear. However, on antigen presenting cells they might participate in the antigen presentation process.
Similar articles
- External glycopeptide binding to MHC class-I in relation to expression of TAP transporters, beta 2-microglobulin and to pH.
Abdel-Motal UM, Dahmén J, Liu T, Ljunggren HG, Jondal M. Abdel-Motal UM, et al. Immunol Lett. 1996 Dec 1;54(1):31-5. doi: 10.1016/s0165-2478(96)02637-5. Immunol Lett. 1996. PMID: 9030979 - The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256-270 glycopeptide to H-2Aq and H-2Ap molecules.
Kjellén P, Brunsberg U, Broddefalk J, Hansen B, Vestberg M, Ivarsson I, Engström A, Svejgaard A, Kihlberg J, Fugger L, Holmdahl R. Kjellén P, et al. Eur J Immunol. 1998 Feb;28(2):755-67. doi: 10.1002/(SICI)1521-4141(199802)28:02<755::AID-IMMU755>3.0.CO;2-2. Eur J Immunol. 1998. PMID: 9521085 - Immunization with glycosylated Kb-binding peptides generates carbohydrate-specific, unrestricted cytotoxic T cells.
Abdel-Motal UM, Berg L, Rosén A, Bengtsson M, Thorpe CJ, Kihlberg J, Dahmén J, Magnusson G, Karlsson KA, Jondal M. Abdel-Motal UM, et al. Eur J Immunol. 1996 Mar;26(3):544-51. doi: 10.1002/eji.1830260307. Eur J Immunol. 1996. PMID: 8605919 - CTL-based cancer preventive/therapeutic vaccines for carcinomas: role of tumour-associated carbohydrate antigens.
Franco A. Franco A. Scand J Immunol. 2005 May;61(5):391-7. doi: 10.1111/j.1365-3083.2005.01596.x. Scand J Immunol. 2005. PMID: 15882430 Review.
Cited by
- Convergent synthesis of neoglycopeptides by coupling of 2-bromoethyl glycosides to cysteine and homocysteine residues in T cell stimulating peptides.
Bengtsson M, Broddefalk J, Dahmén J, Henriksson K, Kihlberg J, Lönn H, Srinivasa BR, Stenvall K. Bengtsson M, et al. Glycoconj J. 1998 Mar;15(3):223-31. doi: 10.1023/a:1006988810800. Glycoconj J. 1998. PMID: 9579799 - A tubular EHD1-containing compartment involved in the recycling of major histocompatibility complex class I molecules to the plasma membrane.
Caplan S, Naslavsky N, Hartnell LM, Lodge R, Polishchuk RS, Donaldson JG, Bonifacino JS. Caplan S, et al. EMBO J. 2002 Jun 3;21(11):2557-67. doi: 10.1093/emboj/21.11.2557. EMBO J. 2002. PMID: 12032069 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous